North America Laboratory Centrifuges Market

North America Laboratory Centrifuges Market Size & Forecast:

• North America Laboratory Centrifuges Market Size 2025: USD 724.3 Million
• North America Laboratory Centrifuges Market Size 2033: USD 1114.1 Million
• North America Laboratory Centrifuges Market CAGR: 5.53% 
• North America Laboratory Centrifuges Market Segments: By Product Type (Benchtop Centrifuges, Floor-Standing Centrifuges, Microcentrifuges, Ultracentrifuges, Refrigerated Centrifuges, Clinical Centrifuges, High-Speed Centrifuges, Others); By Rotor Type (Fixed-Angle Rotors, Swing Bucket Rotors, Vertical Rotors, Drum Rotors, Microplate Rotors, Specialty Rotors, Hybrid Rotors, Others); By Application (Clinical Diagnostics, Cell Culture, Molecular Biology, Blood Component Separation, Pharmaceutical Research, Bioprocessing, Academic Research, Others); By End User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, CROs, Blood Banks, Others); By Capacity (Below 2 L, 2–5 L, 5–10 L, Above 10 L, Compact Systems, Large-Capacity Systems, Multi-Purpose Systems, Others)

North America Laboratory Centrifuges Market Summary

The North America Laboratory Centrifuges Market was valued at USD 724.3 Million in 2025. It is forecast to reach USD 1114.1 Million by 2033. That is a CAGR of 5.53% over the period.

The North America Laboratory Centrifuges Market helps labs handle biological samples, chemical mixtures, and particulate matters with precision, which in turn backs clinical diagnostics, pharma research, biotechnology development, environmental testing, and even universities where prep accuracy is basically the whole point for downstream analysis.In the last three to five years, the whole space started leaning more toward digitally integrated, high-throughput centrifuge setups with automated workflows, remote monitoring, and improved biosafety guardrails, kinda showing that labs care a lot about operational efficiency and data traceability.

One major push, honestly , was the COVID-19 pandemic, because it made the weak spots in lab equipment supply chains way more obvious, while also speeding up molecular testing capacity at a fast pace. To cope, healthcare providers, research organizations, and equipment makers adjusted their sourcing playbooks, expanded onshore production, and leaned toward units with stronger dependability as well as faster sample processing, which reshaped the purchasing patterns and supplier relationships across North America in a pretty fundamental way.

Key Market Insights

• In 2025, the United States pretty much ran the North America Laboratory Centrifuges Market, landing at around 84% market share , this is backed by heavy biotechnology, pharmaceutical, and clinical laboratory spending , not just a little either.
• Canada, though, shows up as the fastest-growing regional market in the 2025–2032 window, largely because life science infrastructure is getting bigger and public research funding keeps moving.
• On the product side , refrigerated laboratory centrifuges take the lead with roughly 38% market share , mainly because molecular diagnostics plus pharmaceutical labs really care about temperature controlled sample handling, even when workflows get busy.
• Benchtop centrifuges sit as the second-largest segment , since medium-throughput labs are still upgrading tools while also trying to stretch laboratory space and keep operating costs in check.
• High-speed centrifuges are forecast to be the quickest growing product category through 2032, driven by newer genomics and proteomics efforts, plus cell therapy workflows that need stronger performance.
• For applications , clinical diagnostics dominate at about 41% market share, which kind of mirrors steady testing demand across hospitals, diagnostic labs, and reference testing centers.
• Biopharmaceutical research and development is expected to grow the most rapidly through the forecast period, supported by expansion in cell and gene therapy manufacturing .
• When it comes to end users, hospitals and diagnostic laboratories stay out front, with roughly 46% market share, helped by ongoing replacement cycles and upgrades to lab capacity.
• Meanwhile , biotechnology and pharmaceutical companies are the fastest-growing end-user group through 2032, and that pattern is tied to continuing investments in precision medicine and biologics development , overall.

What are the Key Drivers, Restraints, and Opportunities in the North America Laboratory Centrifuges Market?

The main factor pushing the North America Laboratory Centrifuges Market forward is the quick growth of molecular diagnostics as well as the move into more advanced biopharmaceutical manufacturing, and honestly it feels like they kinda accelerate each other. After the COVID-19 pandemic, many labs started modernization at large scale. That wave then got kept going by steady funding for precision medicine programs. In practice, labs swapped older centrifuges for more automated, digitally linked systems, these new setups handle higher throughput and they also improve sample traceability. So you see faster procurement cycles, more aggressive equipment replacement activity, and better revenue chances for manufacturers that bundle integrated lab platforms. There’s also the productivity side, which boosts return on investment for healthcare providers and research organizations, it sort of loops back.

Meanwhile, the biggest restraint stays pretty consistent: manufacturing is concentrated, and component sourcing is concentrated too for high-performance laboratory centrifuges. Specialized motors, electronic control systems, and refrigeration modules depend on relatively small supplier networks. Those networks can’t be rearranged or diversified quickly, even if demand spikes. From what Transpire Insight pulled together via regional procurement announcements and launch schedules, the supply chain concentration is still the key execution risk. When delivery times slip, procurement timelines stretch by several months, and that delays lab expansion projects. It also affects how and when revenue is recognized, because installations get pushed out. On top of that, qualification requirements in regulated laboratories make supplier substitution slower, and that adds friction.

The strongest opportunity kind of lies in weaving together intelligent lab ecosystems with connected centrifuge platforms. AI enabled maintenance software, cloud based fleet management and digital laboratory information system integration can lower equipment downtime while also boosting equipment utilization rates, which is a bit of a key here. With that said continued investment in biotechnology manufacturing across the United States and Canada creates favorable conditions for premium centrifuge platforms that mix automation and predictive diagnostics with compliance ready digital documentation. That combination supports the next phase of market expansion and it feels pretty logical overall.

What Has the Impact of Artificial Intelligence Been on the North America Laboratory Centrifuges Market?

Artificial intelligence plus digital technologies are now reshaping lab centrifuge work in a way that feels almost hands off, like the machines are helping manage themselves. With smarter equipment management, automated process control, and a smooth link to laboratory information management systems, centrifuges are doing more than just spinning. Today’s centrifuge platforms can watch key operating parameters—rotor speed, temperature stability, vibration levels, and even cycle history—in real time, which cuts down on the need for constant human attention. At the same time they help labs keep up with regulatory compliance, even when routines get busy or staff are limited.

In the background, machine learning looks at older performance records to anticipate component wear, then it helps line up preventive maintenance before something goes wrong. It also improves utilization across lab networks, so workflows don’t get interrupted by failures. Overall, these features raise equipment availability, reduce sudden downtime, and allow laboratories to allocate their assets more wisely. That typically means less money spent on maintenance across the whole service life of the equipment, not just in the short term.

Digital connectivity also plays a role in inventory planning, for example by forecasting service needs and replacement demand. This helps manufacturers and lab managers make better procurement decisions, instead of guessing based on past patterns. And with advanced analytics, sample processing can become more consistent, because the system can suggest optimized operating settings for different research or diagnostic uses.

Still, even with all these upsides, broad AI adoption is not fully happening everywhere. The main issues are the high integration costs, plus how complicated it can be to connect older lab setups to modern digital platforms. There are also data standardization hurdles and cybersecurity requirements, which slow down progress especially in smaller research labs. Those groups often run mixed fleets from multiple manufacturers, so harmonizing things becomes even more difficult, and the timeline stretches out.

Key Market Trends

• Since 2021, many labs have kinda rushed replacement of older centrifuges, swapping them for more digitally connected setups with touchscreen controls and remote diagnostics , plus automated performance monitoring too.
• Thermo Fisher Scientific, Eppendorf , and Beckman Coulter have really pushed bigger smart laboratory portfolios since 2022, which has made the competition sharper around software-enabled equipment differences.
• After the post-pandemic shift, purchasing priorities leaned more toward domestic and regional suppliers, so dependence on single-source international component manufacturers dropped, especially after 2020 disruptions.
• Also, refrigerated centrifuges seem to have grabbed a larger portion of new installations since 2021, aided by expansion in genomics, proteomics , and cell therapy lab workflows.
• Integration with laboratory information management systems is now basically a default procurement condition, and by 2025 digital traceability is replacing standalone equipment buying across many major research sites.
• Since 2022, energy efficient motor technologies, and more optimized refrigeration systems have been getting way more attention , so labs can bring down their operating costs while still backing institutional sustainability targets.
• Between 2023 and 2025, pharmaceutical and biotechnology firms bumped up their capital spending on automated sample prep platforms, cutting processing timelines, and also keeping workflow uniformity much more stable.
• Since 2023, predictive upkeep via sensor based monitoring has shown up as a competitive advantage, reducing those annoying, unplanned equipment downtimes, and extending service intervals longer than before.
• Finally, regulatory pressure on sample integrity and laboratory quality documentation has nudged wider use of centrifuges that include automated audit trails and electronic data recording, mainly since 2022.

North America Laboratory Centrifuges Market Segmentation

By Product Type :

Benchtop centrifuges tend to keep a solid spot in a lot of workflows , mainly because their compact builds slide in pretty well across hospitals, diagnostic centers,and research labs that have limited work space . Floor standing centrifuges , in contrast ,are made for bigger sample amounts and they just keep going through day to day lab routines. Microcentrifuges still feel hard to replace in molecular biology and genetics, particularly when tiny samples need speed and a lot more precision. Ultracentrifuges keep showing up in higher level studies , such as those focused on proteins, viruses, and nanoparticles,where the atmosphere around the process can get quite demanding.

Refrigerated centrifuges help hold steady temperature conditions while careful sample handling is happening so the instrument stays dependable for biotechnology and pharmaceutical labs. Clinical centrifuges stay broadly useful for routine blood and urine testing across healthcare settings.High speed centrifuges support tougher procedures that need fast separation and consistent performance, every single time. Other specialized units will still find a home in labs that have unique workflow needs, plus those application specific requirements that don’t quite match the standard setups.

By Rotor Type :

Fixed angle rotors make up a large share, because fast sedimentation supports routine lab tests plus research work in a pretty practical way. Swing bucket rotors still feel popular for blood separation, and for clinical sample preparation where even separation helps the result quality come out more reliably. Vertical rotors keep getting used for more specialized purposes, they often need shorter run times and efficient particle separation in the same breath. Drum rotors find their place in certain industrial and research workflows, especially when larger sample handling is involved

Microplate rotors are gaining wider acceptance, as high throughput testing keeps expanding across pharmaceutical and biotechnology laboratories, and yes the demand is growing. Specialty rotors give a more tailored approach for labs that deal with unusual sample types or some unusual testing procedures. Hybrid rotors bring extra flexibility, they can support multiple applications in one laboratory setting without much fuss. Other rotor styles will also stay on hand, for labs that want customized operating capabilities, instead of a one size fits all setup.

By Application :

Clinical diagnostics are maybe the largest application because, well accurate sample preparation actually keeps disease detection dependable and it supports patient care too, so you get more meaningful results. Cell culture work keeps growing, especially alongside regenerative medicine initiatives and the broader push in biologics development. Molecular biology labs still lean on advanced centrifugation systems for DNA , RNA and protein analysis, and yes the details matter there. Blood component separation stays a core activity inside hospitals and also at blood collection facilities, where timing and consistency are everything.

Pharmaceutical research uses advanced equipment all the way through drug discovery as well as formulation studies. Bioprocessing facilities depend on reliable separation technologies that can increase manufacturing efficiency, and also help with product quality, even when conditions get tricky. Academic research institutions continue investing in modern laboratory equipment, to back scientific innovation and those collaborative projects that start new questions. Other applications will keep adding steady demand across environmental testing, food analysis, and forensic laboratories.

By End User :

Hospitals tend to generate quite a bit of equipment buying, because diagnostic testing keeps showing up as a usual routine within patient care. In the middle of that, clinical labs deal with huge sample volumes each day, which helps them keep replacing devices and modernizing without too much interruption. Then pharmaceutical companies put money into more advanced laboratory infrastructure so research output is smoother, while also staying aligned with regulatory compliance. Biotechnology firms keep pushing to enlarge lab capacity too, mainly to back biologics as well as cell based research programs.

Academic research institutes usually keep procurement steady, often through government funding plus ongoing university research efforts. Contract research organizations also raise lab investments as outsourced research work grows across the healthcare sector. Blood banks, for their part, rely on dependable centrifugation systems for safe preparation of blood components, and for storage that does not go sideways. Other end users might be public health laboratories, environmental testing facilities, and industrial research centers as well.

By Capacity :

Below 2 L systems are still kind of common in small laboratories, where routine testing plus limited sample volumes define most of the day to day operations. Equipment in the 2 to 5 L category tends to fit medium-sized labs, balancing throughput with operational efficiency, without getting too bulky. The 5–10 L range works well for larger research and pharmaceutical facilities, because they need more processing capacity in a steady flow. Anything above 10 L is usually for high-volume labs, or industrial applications where continuous processing matters a lot.

Compact systems stay appealing since setup takes up less lab space, and yet they keep dependable performance going. Larger capacity units are used by centralized laboratories that process thousands of samples during busy work schedules, and they do this reliably. Multi-purpose systems add a kind of operational flexibility by supporting different rotor configurations and testing requirements on the same platform. Other capacity choices will keep showing up too, meeting specialized laboratory demands across healthcare, research, and industrial environments.

What are the Key Use Cases Driving the North America Laboratory Centrifuges Market?

Clinical diagnostics still sit as the main reason why hospitals and clinical labs buy equipment, even today . You know, high testing volumes, blood urine, and a bunch of other biological samples really need dependable separation before anything is analyzed. With labs running continuously , and quality standards that are strict , reliable centrifugation systems become an everyday capital decision.

On the other side, pharmaceutical companies and biotech firms are leaning into these same tools for drug discovery, cell culture, and molecular biology work. Contract research organizations also take up more advanced systems to steer outsourced development programs while keeping regulatory paperwork in order and hitting performance demands for the research work itself.

Cell and gene therapy manufacturing is turning into a newer use case, with real long term upside. More advanced bioprocessing facilities , plus precision medicine research programs, will call for higher performance centrifugation platforms, especially for sensitive sample handling. Even environmental testing laboratories are starting to look attractive here as regulatory monitoring grows and lab modernization initiatives keep rolling across North America.

Which Regions are Driving the North America Laboratory Centrifuges Market Growth?

The United States comes in at roughly 84 % of the regional revenue, so it’s basically the main scene across North America. With strong healthcare rules, deep laboratory accreditation standards, and continued public funding for biomedical research, buyers keep moving forward on equipment procurement. There’s also this wider circle of biotechnology companies, pharmaceutical manufacturers, academic research centers, and local production sites, which sort of reinforces the supply ecosystem. Plus, steady investment in lab modernization along with precision medicine programs should keep the market in a leadership spot during the whole forecast.

Canada lands as the second-biggest regional market, built on publicly funded care plus coordinated research spending. Regulatory supervision stays stable, and healthcare spending remains fairly steady too, which then makes purchasing cycles for hospitals, research institutes, and diagnostic laboratories feel more predictable. Government backing for biotechnology research, plus university partnerships, gives laboratory equipment suppliers a dependable platform. Even though the population is smaller and the lab network is narrower, these strengths keep Canada as a dependable recurring revenue source.

Canada is also expected to log the quickest expansion over the 2026–2033 window, as life science infrastructure projects, biotechnology investments, and laboratory modernisation programs keep on speeding up. In fact, the latest public-and private funding rounds for genomics, biomanufacturing, and research capacity have helped spur the purchasing of advanced laboratory centrifuges with digital capabilities. As more domestic research activity ramps up, there are new chances for suppliers that provide automation , energy-efficient systems, and broader service support. This momentum should set up fairly attractive conditions for brand new market entrants and investors looking for longer term growth across the more specialized laboratory segments.

Who are the Key Players in the North America Laboratory Centrifuges Market and How Do They Compete?

Competition stays pretty moderately consolidated, mainly because only a limited number of global manufacturers kind of dominate the premium laboratory centrifuge space. In practice, competitive strength seems to come from things like technological innovation, product dependability, digital integration, and the after-sales support, not just from pricing by itself. The bigger, established brands keep building out their portfolios with more automation and ongoing software progress, while smaller suppliers tend to concentrate on more specific lab needs, you know, application-targeted solutions, or more bespoke laboratory requirements.

Thermo Fisher Scientific sets itself apart with integrated lab workflows, plus it keeps investing in digital lab technologies that raise productivity and make equipment management feel more organized. Eppendorf emphasizes precision engineering, smooth, easy operation, and energy-aware designs that resonate with research teams looking for long equipment life and dependable day-to-day performance. Beckman Coulter leans into connected lab features and automation functions, aiming at high-throughput clinical and research environments where speed and consistency really matter.

Sartorius also moves its position ahead by linking centrifugation instruments with wider bioprocess solutions that are used across biologics manufacturing. Bio-Rad Laboratories tends to focus on compatibility with molecular biology and diagnostic routines, so laboratories can streamline their research work using integrated systems. QIAGEN expands its overall laboratory offerings through technology development and workflow tuning, which ends up creating more value for customers running molecular testing and doing precision medicine use cases.

Company List

Thermo Fisher Scientific

Eppendorf

Beckman Coulter

Sartorius

Hettich

Sigma Laborzentrifugen

Andreas Hettich

Kubota Corporation

NuAire

Hermle Labortechnik

Labnet International

Corning

Bio-Rad Laboratories

Agilent Technologies

Haier Biomedical 

Recent Development News

In April 2025, Beckman Coulter Life Sciences launched the OptiMATE Gradient Maker, an automated density-gradient preparation system for ultracentrifugation. The product reduces gradient preparation time by up to 75%, improving workflow efficiency for biopharma and research laboratories using ultracentrifuges. Sourcehttps://www.beckman.com/

In April 2025, Thermo Fisher Scientific introduced new Thermo Scientific Cryofuge refrigerated floor centrifuge models for precision medicine and high-throughput clinical laboratories. The launch expanded the company's clinical centrifuge portfolio with enhanced automation and higher processing efficiency for healthcare and research customers.

Source https://www.thermofisher.com/

What Strategic Insights Define the Future of the North America Laboratory Centrifuges Market?

Over the next five to seven years, the North America Laboratory Centrifuges Market is set to drift toward more connected, automatic lab platforms that stitch together intelligent controls , predictive maintenance, and smooth integration with digital laboratory systems. In practice, this path is being pushed by steady investment in advanced diagnostics, biopharmaceutical production, and the underlying precision medicine infrastructure, not just a simple case of replacing old gear. There is also a quieter concern, a sort of less visible snag , tied to supply chain concentration for specialized motors, electronic parts, and refrigeration systems. If supplier diversity is narrow , production could get held up even when order pipelines look strong. 

At the same time, an opportunity is forming around centrifuge platforms built for cell and gene therapy manufacturing. With stricter performance expectations and regulatory requirements, the market is likely to favor higher priced equipment and faster premium adoption. In response, players should tighten regional manufacturing collaborations, broaden software-enabled service offerings , and spread sourcing for key components , so resilience improves while long-term chances in advanced life science uses can be captured.

North America Laboratory Centrifuges Market Report Segmentation

By Product Type

• Benchtop Centrifuges
• Floor-Standing Centrifuges
• Microcentrifuges
• Ultracentrifuges
• Refrigerated Centrifuges
• Clinical Centrifuges
• High-Speed Centrifuges

By Rotor Type

• Fixed-Angle Rotors
• Swing Bucket Rotors
• Vertical Rotors
• Drum Rotors
• Microplate Rotors
• Specialty Rotors
• Hybrid Rotors

By Application

• Clinical Diagnostics
• Cell Culture
• Molecular Biology
• Blood Component Separation
• Pharmaceutical Research
• Bioprocessing
• Academic Research

By End User

• Hospitals
• Clinical Laboratories
• Pharmaceutical Companies
• Biotechnology Companies
• Academic Research Institutes
• CROs
• Blood Banks

By Capacity

• Below 2 L
• 2–5 L
• 5–10 L
• Above 10 L
• Compact Systems
• Large-Capacity Systems
• Multi-Purpose Systems